HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying Cui Selected Research

Liver Neoplasms (Liver Cancer)

9/2019HIF-1α-induced RIT1 promotes liver cancer growth and metastasis and its deficiency increases sensitivity to sorafenib.
10/2017Combined use of alcohol in conventional chemical-induced mouse liver cancer model improves the simulation of clinical characteristics of human hepatocellular carcinoma.
11/2014Inhibitory effects of transcription factor Ikaros on the expression of liver cancer stem cell marker CD133 in hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying Cui Research Topics

Disease

89Neoplasms (Cancer)
03/2024 - 11/2007
28Hepatocellular Carcinoma (Hepatoma)
01/2024 - 12/2008
18Neoplasm Metastasis (Metastasis)
10/2022 - 09/2011
12Atherosclerosis
02/2024 - 01/2013
12Breast Neoplasms (Breast Cancer)
10/2023 - 04/2008
11Inflammation (Inflammations)
01/2024 - 04/2014
11Carcinogenesis
10/2022 - 09/2009
10Infections
01/2023 - 01/2015
9Traumatic Brain Injuries (Traumatic Brain Injury)
01/2017 - 01/2014
8Lung Neoplasms (Lung Cancer)
01/2023 - 02/2007
7Fibrosis (Cirrhosis)
04/2024 - 09/2013
7Colonic Neoplasms (Colon Cancer)
03/2024 - 07/2014
7Ischemic Stroke
03/2024 - 01/2018
7Diabetic Retinopathy (Retinopathy, Diabetic)
07/2023 - 12/2020
6Cerebral Hemorrhage
08/2023 - 01/2017
6Carcinoma (Carcinomatosis)
01/2023 - 03/2005
6Brain Edema (Cerebral Edema)
03/2019 - 08/2015
5Necrosis
04/2024 - 04/2017
5Cardiovascular Diseases (Cardiovascular Disease)
12/2023 - 07/2014
5Hypoxia (Hypoxemia)
12/2023 - 11/2013
5Parkinson Disease (Parkinson's Disease)
11/2023 - 11/2020
5Stroke (Strokes)
01/2021 - 03/2015
5Brain Injuries (Brain Injury)
03/2019 - 01/2013
4Atherosclerotic Plaque (Atheroma)
12/2023 - 01/2014
4Nasopharyngeal Carcinoma
11/2023 - 02/2010
4Insulin Resistance
12/2022 - 01/2013
4Cognitive Dysfunction
12/2022 - 01/2019
4Epilepsy (Aura)
10/2022 - 01/2019
4Chronic Renal Insufficiency
02/2022 - 12/2018
4Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 09/2018
4Brain Ischemia (Cerebral Ischemia)
12/2020 - 08/2015
4Glucose Intolerance
01/2019 - 08/2011
3Myocardial Infarction
04/2024 - 11/2013
3Mitochondrial Diseases (Mitochondrial Disease)
01/2023 - 01/2020
3Rheumatoid Arthritis
01/2022 - 02/2016
3Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 01/2014
3Thyroid Neoplasms (Thyroid Cancer)
01/2022 - 11/2020
3Secondary Hyperparathyroidism
11/2021 - 12/2018
3Glioma (Gliomas)
10/2020 - 06/2011
3Liver Neoplasms (Liver Cancer)
09/2019 - 11/2014
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2019 - 11/2014
3Coronary Disease (Coronary Heart Disease)
01/2017 - 03/2011
2Rupture
04/2024 - 04/2014
2Atrial Fibrillation
03/2024 - 01/2022
2Liver Diseases (Liver Disease)
03/2024 - 01/2022

Drug/Important Bio-Agent (IBA)

22Biomarkers (Surrogate Marker)IBA
11/2023 - 11/2014
17Proteins (Proteins, Gene)FDA Link
12/2023 - 09/2009
14MicroRNAs (MicroRNA)IBA
12/2023 - 03/2014
9CytokinesIBA
04/2023 - 05/2015
8Glucose (Dextrose)FDA LinkGeneric
01/2024 - 08/2011
8Neuroprotective AgentsIBA
01/2022 - 05/2014
7Therapeutic UsesIBA
12/2023 - 01/2013
6EnzymesIBA
04/2024 - 12/2008
6Retinaldehyde (Retinal)IBA
11/2023 - 11/2020
6Long Noncoding RNAIBA
10/2022 - 01/2018
5DNA (Deoxyribonucleic Acid)IBA
03/2024 - 09/2011
4AnticoagulantsIBA
03/2024 - 01/2022
4Triglycerides (Triacylglycerol)IBA
01/2024 - 08/2011
4Apolipoproteins E (ApoE)IBA
12/2023 - 04/2014
4CateninsIBA
01/2023 - 09/2020
4Messenger RNA (mRNA)IBA
01/2021 - 09/2009
4Antiviral Agents (Antivirals)IBA
01/2020 - 01/2015
4Interleukin-8 (Interleukin 8)IBA
06/2019 - 01/2013
4Indicators and Reagents (Reagents)IBA
01/2019 - 10/2015
4Small Interfering RNA (siRNA)IBA
02/2016 - 09/2009
3IronIBA
05/2024 - 12/2007
3VaccinesIBA
04/2024 - 01/2018
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2024 - 08/2009
3InterleukinsIBA
01/2024 - 05/2015
3CollagenIBA
12/2023 - 11/2014
3p38 Mitogen-Activated Protein KinasesIBA
12/2023 - 08/2014
3AntioxidantsIBA
03/2023 - 01/2018
3Phosphotransferases (Kinase)IBA
01/2023 - 01/2019
3Adenosine Triphosphate (ATP)IBA
01/2023 - 10/2015
3Interleukin-6 (Interleukin 6)IBA
01/2023 - 11/2013
3LipidsIBA
01/2022 - 01/2016
3Competitive Endogenous RNAIBA
01/2022 - 08/2018
3NitrogenIBA
01/2022 - 12/2019
3oxidized low density lipoproteinIBA
01/2022 - 01/2014
3Sorafenib (BAY 43-9006)FDA Link
01/2022 - 09/2015
3Blood Glucose (Blood Sugar)IBA
01/2022 - 10/2016
3Parathyroid Hormone (Parathormone)IBA
11/2021 - 01/2018
3Becaplermin (PDGF-BB)FDA Link
01/2021 - 08/2014
3Oxygen (Dioxygen)IBA
01/2021 - 04/2018
3Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 01/2020
3Hormones (Hormone)IBA
10/2020 - 07/2018
3Matrix Metalloproteinases (MMPs)IBA
09/2020 - 11/2007
3CalciumIBA
07/2018 - 03/2016
3RNA (Ribonucleic Acid)IBA
01/2018 - 09/2009
3Peptides (Polypeptides)IBA
10/2017 - 01/2013
2Histones (Histone)IBA
03/2024 - 01/2022
2MethyltransferasesIBA
03/2024 - 07/2014
2Vitamin KFDA Link
03/2024 - 01/2023
2LigandsIBA
01/2024 - 01/2019

Therapy/Procedure

35Therapeutics
03/2024 - 08/2009
7Radiotherapy
04/2022 - 02/2007
6Drug Therapy (Chemotherapy)
01/2018 - 08/2009
5Transplantation
12/2023 - 01/2013
5Parathyroidectomy
02/2022 - 12/2018
3Immunotherapy
01/2023 - 05/2014